For Latest IP Related Updates/News
Gene Patents struck down by Australia’s High Court saying that allowing patents of genes were wrong, and they do not constitute a patentable invention. The judges unanimously agreed on the outcome that the key part of a gene is not its physical structure but rather the information stored in it, which is not an invention. They also said that if […]
In a decision issued on September 22, 2015 Judge King ruled the copyright invalid, finding that though Summy Co. may have owned the copyright to “Good Morning to All,” it never had proper rights to the “Happy Birthday” lyrics. The “Happy Birthday” song dates to late 19th century work by a schoolteacher named Patty Smith Hill and her sister Mildred Hill The Hill sisters […]
Indian Patent Office has denied Germany’s Boehringer Ingelheim a patent on its key HIV drug, Nevirapine, for a version sold as Viramune XR (extended release). VIRAMUNE XR was approved in US on Mar 25, 2011 (100 mg and 400 mg, TABLET) and OB listed US patent will expire on Mar. 12, 2015. The application on the Nevirapine extended release formulation […]
New Molecular Entity and New Therapeutic Biological Product Approvals Drug Name Active Ingredient Date FDA-approved use on approval date Daklinza daclatasvir 7/24/2015 To treat chronic hepatitis C virus (HCV) genotype 3 infections Odomzo sonidegib 7/24/2015 To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation […]
Original New Drug Application (NDA and BLA) Approvals-November 2015 Active Ingredient(s) Company Approval Date MEPOLIZUMAB GLAXOSMITHKLINE LLC 11/04/2015 ELVITEGRAVIR;COBICISTAT;EMTRICITABINE;TENOFOVIR ALAFENAMIDE GILEAD SCIENCES INC 11/05/2015 HALOBETASOL PROPIONAT FERNDALE LABS 11/06/2015 COBIMETINIB GENENTECH INC 11/10/2015 OSIMERTINIB ASTRAZENECA PHARMS 11/13/2015 DARATUMUMAB JANSSEN BIOTECH 11/16/2015 NALOXONE HYDROCHLORIDE ADAPT 11/18/2015 IXAZOMIB MILLENNIUM PHARMS 11/20/2015